Will you be in #Frankfurt for #EBMT2019 ? Our colleague will be presenting a poster on "Performance Parameters of an NGS Product for Chimerism Monitoring" - you can also visit us at booth B2 to learn more!
#Chimerism#NGS#genetictesting#Devyser#EBMT
Are you our next colleague? Devyser is recruiting a field application specialist to provide pre-and post-sale support for our Next Generation Sequencing (NGS), Capillary Electrophoresis (CE) and real-time PCR (qPCR) product lines.
#Devyser#jobsinbiotech
https://t.co/AvRHPYiEys
Are you attending the Industry Forum Human Genetics next week in Weimar? Come and say hello to us at booth 45.2 ! #devyser#weimar#kongress#humangenetics
Big conferences can be exciting, but we love small conferences too, come and have a chat at BVDH in Cologne today and tomorrow, and learn about our new products! You can't miss us - we're right by the lecture hall and colourful Russian spires! #BVDH#Devyser#Conference#biotech
We're currently searching for an International Area Sales Manager! Based in Stockholm, this role is for someone with a background in Molecular Biology or Genetics who loves being out in the field meeting with customers to develop the business. https://t.co/UqFq9Izb7L
Today is #FHAwarenessDay - raising awareness for the role that #FamilialHypercholesterolemia plays in cholesterol, heart disease and cardiac events. Read more about the latest science at https://t.co/ncidxPPHqo
“QF-PCR - a fast and reliable method for prenatal aneuploidy analysis and determination of maternal cell contamination” Our Technical EM, Sandra Kazemi, presents tonight 18:40 at the Polish Human Genetics Congress, Bydgoszcz!
#genetics#mcc#maternalcellcontamination
An expert panel has promoted genetic testing for Familial Hypercholesterolemia (FH) as a standard of care. As outlined in a recent article (Sturm et al 2018), this common and potentially fatal condition is treatable, but vastly underdiagnosed. https://t.co/IdSyPAIumR
When testing prenatal samples derived from chorionic villus or amniocentesis, there is a risk of misdiagnosis due to maternal cell contamination (MCC). This application note addresses determining MCC levels when using the Devyser Compact kit. Read now: https://t.co/Rb2RDL4Puy
FH is a greatly underdiagnosed autosomal disorder, with most patients suffering a cardiovascular event prior to diagnosis. This paper offers advice on genetic testing for FH, and outlines using NGS for cascade screening of related individuals. https://t.co/5eDTM1ngcY
Join us to explore A Simple NGS Method for Detection of Mutations Causing Alpha and Beta Thalassemia! Poster PS1512, presented 17:30 - 19:00 this Saturday 16th of June at the 23rd Congress of the European Hematology Association
#EHA2018#EHA23#Thalassemia#NGS
Devyser is proud to have once again been certified a Great Place to Work!
Thank you to the team at @gptw_sverige for hosting us last week for a workshop, brainstorming and sharing stories of best practice in the workplace! #GPTW#Devyser#workplaceculture#weloveourwork
Genome-wide somatic variant calling using localized colored de Bruijn graphs, by @gnarzisi and my @nygenome’s colleagues!
https://t.co/tXQ1ikfwA3
https://t.co/kQFb2L5V8B
The #GFH Congress is now underway in Münster, we'd love to speak to you about #NGS and #genetic testing for personalised medicine. Come visit us at booth 20 today or tomorrow!
#bioinformatics#cftr#genetics#testing